We are live on
!
Find out more
GP
Geneva Partners Portfolio holdings
AUM
$375M
1-Year Est. Return
131.24%
This Fund
S&P 500
This Quarter
Est. Return
+63.68%
1 Year Est. Return
+131.24%
3 Year Est. Return
+400.69%
5 Year Est. Return
+687.84%
10 Year Est. Return
–
AUM
$375M
AUM Growth
+$167M
(+80%)
Cap. Flow
+$78.9M
Cap. Flow
% of AUM
21.04%
Top 10 Holdings %
Top 10 Hldgs %
41.06%
Holding
81
New
18
Increased
32
Reduced
22
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$13.6M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$12.8M |
| 3 |
Teradyne
TER
|
+$10.8M |
| 4 |
Corning
GLW
|
+$9.04M |
| 5 |
Bloom Energy
BE
|
+$7.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Health Care ETF
VHT
|
+$8.04M |
| 2 |
Eli Lilly
LLY
|
+$3.76M |
| 3 |
O'Reilly Automotive
ORLY
|
+$3.49M |
| 4 |
Hershey
HSY
|
+$2.69M |
| 5 |
Applied Optoelectronics
AAOI
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.44% |
| 2 | Miscellaneous | 22.43% |
| 3 | Industrials | 20.38% |
| 4 | Communication Services | 5.93% |
| 5 | Energy | 4.18% |
Similar funds
PCM
FLI
CCM
SBF
SPFSPD
HIC
WIC
BAM
Geneva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Geneva Partners held 81 positions worth $375M, up 80% from $208M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Geneva Partners deployed $78.9M of net new capital in Q2 2026, opening 18 new positions and adding to 32 existing holdings. Its largest new stake was Marvell Technology: 68,048 shares worth $20.3M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.
On the sell side, the largest reduction was Eli Lilly, an estimated $3.76M trimmed.
- Geneva Partners's largest Q2 2026 buy was Marvell Technology: 68,048 shares worth $20.3M.
- Geneva Partners added most to Dell in Q2 2026, an estimated $4.08M increase.
- Geneva Partners's biggest Q2 2026 reduction was Eli Lilly, cutting an estimated $3.76M.
- Geneva Partners fully exited Vanguard Health Care ETF in Q2 2026, selling an estimated $8.04M.
- Geneva Partners's ten largest holdings make up 41% of its $375M portfolio in Q2 2026.
- Geneva Partners opened 18 new positions and closed 6 in Q2 2026.
- Geneva Partners's portfolio value rose 80% quarter-over-quarter to $375M.
Based on Geneva Partners's 13F filing for Q2 2026, filed 10 Aug 2026.